Downregulation of LncRNA SNHG7 Sensitizes Colorectal Cancer Cells to Resist Anlotinib by Regulating MiR-181a-5p/GATA6

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2023 Jan 24

PMID 36691432

Authors

Deng Pan

Kehe Chen

Ping Chen

Yu Liu

Yingying Wu

Jingning Huang

Affiliations

Soon will be listed here.

Abstract

Long noncoding RNAs are a novel class of regulators in human cancers. It has been reported that small nucleolar RNA hostgene 7 (SNHG7) can sponge microRNAs to regulate colorectal cancer (CRC) progression. Given its important regulatory role in cancer biology, we wondered whether SNHG7 is involved in drug resistance to anlotinib (ATB) in CRC. To answer this, we quantified the expression of SNHG7 by quantitative real-time PCR. We performed the Cell Counting Kit-8 and Colony formation assay, flow cytometric analysis, RNA pull-down, RNA-binding protein immunoprecipitation assay, and Luciferase reporter assay to confirm the interaction among SNHG7, miR-181a-5p, and GATA6. We found that SNHG7 was significantly upregulated in CRC tissues and cell lines and ATB-resistant cell lines, which was closely related to the poor overall survival of patients. Loss-of-function studies demonstrated that SNHG7 knockdown can inhibit CRC cell proliferation, increase apoptosis, and sensitize CRC cells to resist ATB. Mechanistic studies showed that SNHG7 acted as a competitive endogenous RNA to sponge miR-181a-5p to regulate the expression of GATA6, thereby promoting ATB resistance in ATB-resistant cell lines. In conclusion, SNHG7 plays an important role in ATB resistance, and it may be used to monitor ATB resistance in CRC.

Citing Articles

Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances.

Chong Z, Ho W, Yeap S Noncoding RNA Res. 2024; 11:73-90.

PMID: 39736850 PMC: 11683247. DOI: 10.1016/j.ncrna.2024.11.005.

Disulfidptosis-related long non-coding RNA signature predicts the prognosis, tumor microenvironment, immunotherapy, and antitumor drug options in colon adenocarcinoma.

Wang K, Yu J, Xu Q, Peng Y, Li H, Lu Y Apoptosis. 2024; 29(11-12):2074-2090.

PMID: 39115621 PMC: 11550253. DOI: 10.1007/s10495-024-02011-x.

References

Chi J, Liu S, Wu Z, Shi Y, Shi C, Zhang T . circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR‑181a‑5p/ROCK2 axis. Oncol Rep. 2021; 46(1). PMC: 8165598. DOI: 10.3892/or.2021.8093. View

Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R . Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004; 36(1):40-5. DOI: 10.1038/ng1285. View

Yan L, Zhang D, Mo S, Yuan H, Mo X, Zhao J . Anlotinib suppresses metastasis and multidrug resistance dual blockade of MET/ABCB1 in colorectal carcinoma cells. J Cancer. 2021; 12(7):2092-2104. PMC: 7974540. DOI: 10.7150/jca.45618. View

Wang C, Chen J, Cao W, Sun L, Sun H, Liu Y . Aurora-B and HDAC synergistically regulate survival and proliferation of lymphoma cell via AKT, mTOR and Notch pathways. Eur J Pharmacol. 2015; 779:1-7. DOI: 10.1016/j.ejphar.2015.11.049. View

Neguembor M, Jothi M, Gabellini D . Long noncoding RNAs, emerging players in muscle differentiation and disease. Skelet Muscle. 2014; 4(1):8. PMC: 3973619. DOI: 10.1186/2044-5040-4-8. View

Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris J . The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 2006; 21(3):743-53. PMC: 1847772. DOI: 10.1096/fj.06-6830com. View

Sun Y, Niu W, Du F, Du C, Li S, Wang J . Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. J Hematol Oncol. 2016; 9(1):105. PMC: 5051080. DOI: 10.1186/s13045-016-0332-8. View

Lee E, Gusev Y, Jiang J, Nuovo G, Lerner M, Frankel W . Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2006; 120(5):1046-54. PMC: 2680248. DOI: 10.1002/ijc.22394. View

Shen H, Weng X, Liu X, Yang D, Wang L, Guo J . miR-181a-5p is downregulated and inhibits proliferation and the cell cycle in prostate cancer. Int J Clin Exp Pathol. 2020; 11(8):3969-3976. PMC: 6962816. View

10.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

11.

Han P, Li J, Zhang B, Lv J, Li Y, Gu X . The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer. 2017; 16(1):9. PMC: 5237133. DOI: 10.1186/s12943-017-0583-1. View

12.

Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B . Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol. 2018; 11(1):89. PMC: 6029165. DOI: 10.1186/s13045-018-0632-2. View

13.

Song X, Xue Y, Cai H . Down-Regulation of miR-181a-5p Prevents Cerebral Ischemic Injury by Upregulating En2 and Activating Wnt/β-catenin Pathway. J Stroke Cerebrovasc Dis. 2020; 30(3):105485. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105485. View

14.

Beuling E, Baffour-Awuah N, Stapleton K, Aronson B, Noah T, Shroyer N . GATA factors regulate proliferation, differentiation, and gene expression in small intestine of mature mice. Gastroenterology. 2011; 140(4):1219-1229.e1-2. PMC: 3541694. DOI: 10.1053/j.gastro.2011.01.033. View

15.

Shan Y, Ma J, Pan Y, Hu J, Liu B, Jia L . LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 2018; 9(7):722. PMC: 6006356. DOI: 10.1038/s41419-018-0759-7. View

16.

Xie Y, Wang Y, Gong R, Lin J, Li X, Ma J . SNHG7 Facilitates Hepatocellular Carcinoma Occurrence by Sequestering miR-9-5p to Upregulate CNNM1 Expression. Cancer Biother Radiopharm. 2020; 35(10):731-740. DOI: 10.1089/cbr.2019.2996. View

17.

Sun T, Yin L, Kuang H . miR-181a/b-5p regulates human umbilical vein endothelial cell angiogenesis by targeting PDGFRA. Cell Biochem Funct. 2019; 38(2):222-230. DOI: 10.1002/cbf.3472. View

18.

Sun X, Huang T, Liu Z, Sun M, Luo S . LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway. Eur J Pharmacol. 2019; 856:172407. DOI: 10.1016/j.ejphar.2019.172407. View

19.

Yang B, Mao L, Li Y, Li Q, Li X, Zhang Y . β-catenin, leucine-rich repeat-containing G protein-coupled receptor 5 and GATA-binding factor 6 are associated with the normal mucosa-adenoma-adenocarcinoma sequence of colorectal tumorigenesis. Oncol Lett. 2018; 15(2):2287-2295. PMC: 5777020. DOI: 10.3892/ol.2017.7566. View

20.

Kawasaki Y, Matsumura K, Miyamoto M, Tsuji S, Okuno M, Suda S . REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis. Sci Rep. 2015; 5:14291. PMC: 4585703. DOI: 10.1038/srep14291. View